Magyari M - Search Results

1

Risk of cardiovascular disease in patients with multiple sclerosis treated with fingolimod compared to natalizumab: A nationwide cohort study of 2095 patients in Denmark.

Framke E, Thygesen LC, Malmborg M, Schou M, Sellebjerg F, Magyari M. Framke E, et al. Among authors: magyari m. Mult Scler. 2024 Feb;30(2):184-191. doi: 10.1177/13524585231221415. Epub 2024 Jan 11. Mult Scler. 2024. PMID: 38205784

2

Reproduction and the risk of multiple sclerosis.

Magyari M, Koch-Henriksen N, Pfleger CC, Sørensen PS. Magyari M, et al. Mult Scler. 2013 Oct;19(12):1604-9. doi: 10.1177/1352458513481397. Epub 2013 Mar 18. Mult Scler. 2013. PMID: 23508651

3

Gender and autoimmune comorbidity in multiple sclerosis.

Magyari M, Koch-Henriksen N, Pfleger CC, Sørensen PS. Magyari M, et al. Mult Scler. 2014 Aug;20(9):1244-51. doi: 10.1177/1352458514521515. Epub 2014 Feb 5. Mult Scler. 2014. PMID: 24500604

4

Preserved in vivo response to interferon-alpha in multiple sclerosis patients with neutralising antibodies against interferon-beta (REPAIR study).

Magyari M, Bach Søndergaard H, Sellebjerg F, Soelberg Sørensen P. Magyari M, et al. Mult Scler Relat Disord. 2013 Apr;2(2):141-6. doi: 10.1016/j.msard.2012.10.001. Epub 2012 Dec 11. Mult Scler Relat Disord. 2013. PMID: 25877635

5

Registers of multiple sclerosis in Denmark.

Koch-Henriksen N, Magyari M, Laursen B. Koch-Henriksen N, et al. Among authors: magyari m. Acta Neurol Scand. 2015;132(199):4-10. doi: 10.1111/ane.12424. Acta Neurol Scand. 2015. PMID: 26046552 Review.

6

Physical and social environment and the risk of multiple sclerosis.

Magyari M, Koch-Henriksen N, Pfleger CC, Sørensen PS. Magyari M, et al. Mult Scler Relat Disord. 2014 Sep;3(5):600-6. doi: 10.1016/j.msard.2014.07.002. Epub 2014 Jul 21. Mult Scler Relat Disord. 2014. PMID: 26265272

7

Risk of multiple sclerosis during tumour necrosis factor inhibitor treatment for arthritis: a population-based study from DANBIO and the Danish Multiple Sclerosis Registry.

Dreyer L, Magyari M, Laursen B, Cordtz R, Sellebjerg F, Locht H. Dreyer L, et al. Among authors: magyari m. Ann Rheum Dis. 2016 Apr;75(4):785-6. doi: 10.1136/annrheumdis-2015-208490. Epub 2015 Dec 23. Ann Rheum Dis. 2016. PMID: 26698850 No abstract available.

8

Self-rated health in women prior to clinical onset of multiple sclerosis: A study within the Danish National Birth Cohort.

Nielsen NM, Harpsøe MC, Simonsen J, Stenager E, Magyari M, Koch-Henriksen N, Frisch M, Bager P. Nielsen NM, et al. Among authors: magyari m. Mult Scler. 2016 Oct;22(11):1444-1451. doi: 10.1177/1352458515621623. Epub 2016 Jan 8. Mult Scler. 2016. PMID: 26746810

9

A comparison of multiple sclerosis clinical disease activity between patients treated with natalizumab and fingolimod.

Koch-Henriksen N, Magyari M, Sellebjerg F, Soelberg Sørensen P. Koch-Henriksen N, et al. Among authors: magyari m. Mult Scler. 2017 Feb;23(2):234-241. doi: 10.1177/1352458516643393. Epub 2016 Jul 11. Mult Scler. 2017. PMID: 27055806

10

High-dose erythropoietin in patients with progressive multiple sclerosis: A randomized, placebo-controlled, phase 2 trial.

Schreiber K, Magyari M, Sellebjerg F, Iversen P, Garde E, Madsen CG, Börnsen L, Romme Christensen J, Ratzer R, Siebner HR, Laursen B, Soelberg Sorensen P. Schreiber K, et al. Among authors: magyari m. Mult Scler. 2017 Apr;23(5):675-685. doi: 10.1177/1352458516661048. Epub 2016 Aug 5. Mult Scler. 2017. PMID: 27481206 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

205 results

Search Page

Filters